1º Dia - 24/03/23
2º Dia - 25/03/23

Atualização em vacinas contra o HPV Voltar

Maricy Tacla Alves Barbosa

Conferência 3 - Agildo Pereira Leal

Artigo Autor(es) Referência
An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy. Yousefi Zahra, Aria Hamid, Ghaedrahmati Farhoodeh, Bakhtiari Tahereh, Azizi Mahdieh, Bastan Reza, Hosseini Reza, Eskandari Nahid Frontiers in immunology. 2021 ; 12():805695. doi: 10.3389/fimmu.2021.805695. pii: .
Combination therapy between prophylactic and therapeutic human papillomavirus (HPV) vaccines with special emphasis on implementation of nanotechnology. Gohar Asmaa, Ali Aya A, Elkhatib Walid F, El-Sayyad Gharieb S, Elfadil Dounia, Noreddin Ayman M Microbial pathogenesis. 2022 Sep; 171(Sep):105747. doi: 10.1016/j.micpath.2022.105747. pii: S0882-4010(22)00360-6.
Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer. Kamolratanakul Supitcha, Pitisuttithum Punnee Vaccines. 2021 Nov; 9(Nov):doi: 10.3390/vaccines9121413. pii: 1413.
Human Papillomavirus Vaccines. Markowitz Lauri E, Schiller John T The Journal of infectious diseases. 2021 Sep; 224(Sep):S367-S378. doi: 10.1093/infdis/jiaa621. pii: .
Human Papillomavirus Vaccines: An Updated Review. Cheng Liqin, Wang Yan, Du Juan Vaccines. 2020 Jul; 8(Jul):doi: 10.3390/vaccines8030391. pii: E391.
Human papillomavirus vaccines: A great leap forward. Frevert Marie Louise, Taran Florin-Andrei Case reports in women's health. 2022 Jan; 33(Jan):e00388. doi: 10.1016/j.crwh.2022.e00388. pii: .
Maximising the potential of HPV vaccines. Luttjeboer Jos, Wondimu Abrham, Van der Schans Jurjen, Postma Maarten J The Lancet. Global health. 2020 Apr; 8(Apr):e460-e461. doi: 10.1016/S2214-109X(20)30073-5. pii: S2214-109X(20)30073-5.
New Perspectives in Therapeutic Vaccines for HPV: A Critical Review. Gardella Barbara, Gritti Andrea, Soleymaninejadian Ehsan, Pasquali Marianna Francesca, Riemma Gaetano, La Verde Marco, Schettino Maria Teresa, Fortunato Nicola, Torella Marco, Dominoni Mattia Medicina (Kaunas, Lithuania). 2022 Jun; 58(Jun):doi: 10.3390/medicina58070860. pii: 860.
Physiopathology and effectiveness of therapeutic vaccines against human papillomavirus. Ayesha Noor, Aboulaghras Sara, Jahangeer Muhammad, Riasat Areej, Ramzan Rehana, Fatima Rameen, Akram Muhammad, Balahbib Abdelaali, Bouyahya Abdelhakim, Sepiashvili Ekaterina, Zengin Gokhan, Shariati Mohammad Ali Environmental science and pollution research international. 2021 Sep; 28(Sep):47752-47772. doi: 10.1007/s11356-021-15441-w. pii: .
Special Issue: HPV and HPV Vaccines. Hibma Merilyn Viruses. 2022 Jan; 14(Jan):doi: 10.3390/v14020274. pii: 274.
Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccines. Stanley Margaret, Joura Elmar, Yen Glorian P, Kothari Smita, Luxembourg Alain, Saah Alfred, Walia Anuj, Perez Gonzalo, Khoury Hanane, Badgley Danielle, Brown Darron R Vaccine. 2021 Feb; doi: 10.1016/j.vaccine.2021.01.060. pii: S0264-410X(21)00099-2.
The Development of Human Papillomavirus (HPV) Vaccines and Current Barriers to Implementation. Butterfield Rebecca, Dhanani Salimah Immunological investigations. 2021 Mar; 1-12. doi: 10.1080/08820139.2021.1897612. pii: .
Update on Safety and Efficacy of HPV Vaccines: Focus on Gardasil. Soliman Monica, Oredein Ololade, Dass Crispin R International journal of molecular and cellular medicine. 2021 ; 10():101-113. doi: 10.22088/IJMCM.BUMS.10.2.101. pii: .
Nenhuma revista foi definida para este congresso.